Pleural Fibrosis

Clinics in Chest Medicine

Volumn 27, Issue 2, 2006, Pages 181-191

  Jantz, Michael A ^a   Antony, Veena B ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; BASIC FIBROBLAST GROWTH FACTOR; FIBRIN; PLATELET DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

CORONARY ARTERY BYPASS GRAFT; HEMATOTHORAX; HUMAN; PATHOGENESIS; PLEURA BIOPSY; PLEURAL FIBROSIS; PRIORITY JOURNAL; REVIEW; TUBERCULOUS PLEURISY;

ASBESTOSIS; CORONARY ARTERY BYPASS; EPITHELIAL CELLS; FIBRIN; FIBROBLAST GROWTH FACTOR 2; FIBROSIS; HEMOTHORAX; PLATELET-DERIVED GROWTH FACTOR; PLEURA; PLEURAL DISEASES; PLEURISY; TUBERCULOSIS, PLEURAL;

EID: 33646577187     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccm.2005.12.003     Document Type: Review

References (116)

1. Antony V.B. Immunological mechanisms in pleural disease. Eur Respir J 21 (2003) 539-544
2. Mutsaers S.E. Mesothelial cells: their structure, function, and role in serosal repair. Respirology 7 (2002) 171-191
3. Antony V.B., Hott J.W., Kunkel S.L., et al. Pleural mesothelial cell expression of C-C (monocyte chemotactic peptide) and C-X-C (interleukin 8) chemokines. Am J Respir Cell Mol Biol 12 (1995) 581-588
4. Nasreen N., Hartman D.L., Mohammed K.A., et al. Talc-induced expression of C-C and C-X-C chemokines and intercellular adhesion molecule-1 in mesothelial cells. Am J Respir Crit Care Med 158 (1998) 971-978
5. Visser C.E., Steenbergen J.J., Betges M.G., et al. Interleukin-8 production by human mesothelial cells after direct stimulation with staphylococci. Infect Immun 63 (1995) 4206-4209
6. Tanaka S., Choe N., Iwagaki A., et al. Asbestos exposure induces MCP-1 secretion by pleural mesothelial cells. Exp Lung Res 26 (2000) 241-255
7. Nasreen N., Mohammed K.A., Hardwick J., et al. Polar production of interleukin-8 by mesothelial cells promotes the transmesothelial migration of neutrophils: role of intercellular adhesion molecule-1. J Infect Dis 183 (2001) 1638-1645
8. Betjes M.G., Tuk C.W., Struijk D.G., et al. Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-alpha, interleukin-1, and medium conditioned by macrophages cocultured with Staphylococcus epidermidis. J Infect Dis 168 (1993) 1202-1210
9. Li F.K., Davenport A., Robson R.L., et al. Leukocyte migration across human peritoneal mesothelial cells is dependent on directed chemokine secretion and ICAM-1 expression. Kidney Int 54 (1998) 2170-2183
10. Zeillemaker A.M., Mul F.P., Hoynck van Papendrecht A.A., et al. Polarized secretion of interleukin-8 by human mesothelial cells: a role in neutrophil migration. Immunology 84 (1995) 227-232
11. Liberek T., Topley N., Luttmann W., et al. Adherence of neutrophils to human peritoneal mesothelial cells; role of intercellular adhesion molecule-1. J Am Soc Nephrol 7 (1996) 208-217
12. Cannistra S.A., Ottensmeier C., Tidy J., et al. Vascular cell adhesion molecule-1 expressed by peritoneal mesothelium partly mediates the binding of activated T lymphocytes. Exp Hematol 22 (1994) 996-1002
13. Jonjic N., Peri G., Bernasconni S., et al. Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 176 (1992) 1165-1175
14. Goodman R.B., Wood R.G., Martin T.R., et al. Cytokine-stimulated human mesothelial cells produce chemotactic activity for neutrophils including Nap-1/IL-8. J Immunol 148 (1992) 457-465
15. Antony V.B., Godbey S.W., Kunkel S.L., et al. Recruitment of inflammatory cells to the pleural space. Chemotactic cytokines, IL-8, and monocyte chemotactic peptide-1 in human pleural fluids. J Immunol 151 (1993) 7216-7223
16. Lee Y.C., and Lane K.B. The many faces of transforming growth factor-beta in pleural diseases. Curr Opin Pulm Med 7 (2001) 173-179
17. Antony V.B., Sahn S.A., Mossman B., et al. Pleural cell biology in health and disease. Am Rev Respir Dis 145 (1992) 1236-1239
18. Harvey W., and Amlot P.L. Collagen production by human mesothelial cells in vitro. J Pathol 19 (1993) 445-452
19. Ma C., Tarnuzzer R.W., and Chegini N. Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-beta 1. Wound Repair Regen 7 (1999) 477-485
20. Idell S., Zweib C., Kumar A., et al. Pathways of fibrin turnover of human pleural mesothelial cells in vitro. Am J Respir Cell Mol Biol 7 (1992) 414-426
21. Falk P., Ma C., Chegini N., et al. Differential regulation of mesothelial cell fibrinolysis by transforming growth factor beta 1. Scan J Clin Lab Invest 60 (2000) 439-447
22. Sasse S.A., Jadus M.R., and Kukes G.D. Pleural fluid transforming growth factor-beta1 correlates with pleural fibrosis in experimental empyema. Am J Respir Crit Care Med 168 (2003) 700-705
23. Maeda J., Ueki N., Oshkawa T., et al. Local production and localization of transforming growth factor-beta in tuberculous pleurisy. Clin Exp Immunol 92 (1993) 32-38
24. Jagirdar J., Lee T.C., Reibman J., et al. Immunohistochemical localization of transforming growth factor beta isoforms in asbestos-related diseases. Environ Health Perspect 105 Suppl 5 (1997) 1197-1203
25. Light R.W., Cheng D.S., Lee Y.C.G., et al. A single intrapleural injection of transforming growth factor beta-2 produces an excellent pleurodesis in rabbits. Am J Respir Crit Care Med 162 (2000) 98-104
26. Lee Y.C.G., Lane K.B., Parker R.E., et al. Transforming growth factor beta-2 (TGF-β2) produces effective pleurodesis in sheep with no systemic complications. Thorax 55 (2000) 1058-1062
27. Mutsaers S.E., McAnulty R.J., Laurent G.J., et al. Cytokine regulation of mesothelial cell proliferation in vitro. Eur J Cell Biol 72 (1997) 24-29
28. Bikfalvi A., Klein S., Pintucci G., et al. Biologic roles of fibroblast growth factor-2. Endocr Rev 18 (1997) 26-45
29. Folkman J., Klagsbrun M., Sasse J., et al. A heparin-binding angiogenic protein-basic fibroblast growth factor-is stored within basement membrane. Am J Pathol 130 (1988) 393-400
30. Friesel R.E., and Maciag T. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction. FASEB J 9 (1995) 919-925
31. Abramov Y., Anteby S.O., Fasouliotis S.J., et al. Markedly elevated levels of vascular endothelial growth factor, fibroblast growth factor, and interleukin 6 in Meigs syndrome. Am J Obstet Gynecol 184 (2001) 354-355
32. Strizzi L., Vianale G., Catalano A., et al. Basic fibroblast growth factor in mesothelioma pleural effusions: correlation with patient survival and angiogenesis. Int J Oncol 18 (2001) 1093-1098
33. Antony V.B., Nasreen N., Mohammed K.A., et al. Talc pleurodesis: basic fibroblast growth factor mediates pleural fibrosis. Chest 126 (2004) 1522-1528
34. Owens M.W., and Milligan S.A. Growth factor modulation of rat pleural mesothelial cell mitogenesis and collagen synthesis. Effects of epidermal growth factor and platelet-derived factor. Inflammation 18 (1994) 77-87
35. Waters C.M., Chang J.Y., Glucksberg M.R., et al. Mechanical forces alter growth factor release by pleural mesothelial cells. Am J Physiol 272 3 Part 1 (1997) L552-L557
36. Safi A., Sadmi M., Martinet N., et al. Presence of elevated levels of platelet-derived growth factor (PDGF) in lung adenocarcinoma pleural effusions. Chest 102 (1992) 204-207
37. Heldin P., Asplund T., Ytterberg D., et al. Characterization of the molecular mechanism involved in the activation of hyaluronan synthetase by platelet-derived growth factor in human mesothelial cells. Biochem J 283 (1992) 165-170
38. Adamson I.Y.R., Prieditis H., and Young L. Lung mesothelial cell and fibroblast responses to pleural and alveolar macrophage supernatants and to lavage fluids from crocidolite-exposed rats. Am J Respir Cell Mol Biol 16 (1997) 650-656
39. Pierce G.F., Mustoe T.A., Lingelbach J., et al. Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J Cell Biol 109 (1989) 429-440
40. Idell S. Pleural fibrosis. In: Light R.W., and Lee Y.C.G. (Eds). Textbook of pleural diseases (2003), Arnold Publishing, London 96-108
41. Mutsaers S.E., Prele C.M., Brody A.R., et al. Pathogenesis of pleural fibrosis. Respirology 9 (2004) 428-440
42. Idell S., Girard W., Koenig K.B., et al. Abnormalities of fibrin turnover in the human pleural space. Am Rev Respir Dis 144 (1991) 187-194
43. McGee M., and Rothberger H. Tissue factor in bronchoalveolar lavage fluids. Evidence for an alveolar macrophage source. Am Rev Respir Dis 131 (1985) 331-336
44. Idell S., Zwieb C., Boggaram J., et al. Mechanisms of fibrin formation and lysis by human lung fibroblasts: influence of TGF-β and TNF-α. Am J Physiol 263 4 Part 1 (1992) L487-L494
45. Bajaj M.S., Pendurthi U., Koenig K., et al. Tissue factor pathway inhibitor expression by human pleural mesothelial and mesothelioma cells and lung fibroblasts. Eur Respir J 15 (2000) 1069-1078
46. Vassalli J.D., Sappino A.P., and Berlin D. The plasminogen activator/plasmin system. J Clin Invest 88 (1991) 1067-1072
47. Shetty S., Kumar A., Johnson A.R., et al. Regulation of mesothelial cell mitogenesis by antisense oligonucleotides for the urokinase receptor. Antisense Res Dev 5 (1995) 307-314
48. Sitrin R.G., Todd III R.F., Albrecht E., et al. The urokinase receptor (CD87) facilitates CD11b/CD18-mediated adhesion of human monocytes. J Clin Invest 97 (1996) 1942-1951
49. Shetty S., and Idell S. A urokinase receptor mRNA binding protein from rabbit lung fibroblasts and mesothelial cells. Am J Physiol 274 Part 1 (1998) L871-L872
50. Chapman H.A. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr Opin Cell Biol 9 (1997) 714-724
51. Shetty S., Kumar A., Johnson A.R., et al. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs. Am J Respir Cell Mol Biol 15 (1996) 78-87
52. Hillerdal G. Pleural plaques in a health survey material. Frequency, development and exposure to asbestos. Scand J Respir Dis 59 (1978) 257-263
53. Bourbeau J., Ernst P., Chrome J., et al. The relationship between respiratory impairment and asbestos-related pleural abnormality in an active work force. Am Rev Respir Dis 142 (1990) 837-842
54. Oliver L.C., Eisen E.A., Greene R., et al. Asbestos-related pleural plaques and lung function. Am J Ind Med 14 (1988) 649-656
55. Hillerdal G. The pathogenesis of pleural plaques and pulmonary asbestosis: possibilities and impossibilities. Eur J Respir Dis 61 (1980) 129-138
56. Robledo R., and Mossman B. Cellular and molecular mechanisms of asbestos-induced fibrosis. J Cell Physiol 180 (1999) 158-166
57. Kawahara M., and Kagan E. The mesothelial cell and its role in asbestos-induced pleural injury. Int J Exp Pathol 76 (1995) 163-170
58. Lilis R., Lerman Y., and Selikoff I.J. Symptomatic benign pleural effusions among asbestos insulation workers: residual radiographic abnormalities. Br J Ind Med 45 (1988) 443-449
59. Hillerdal G. Non-malignant asbestos pleural disease. Thorax 36 (1981) 669-675
60. de Klerk N.H., Cookson W.O., Musk A.W., et al. Natural history of pleural thickening after exposure to crocidolite. Br J Ind Med 46 (1989) 461-467
61. Yates D.H., Browne K., Stidolph P.N., et al. Asbestos-related bilateral diffuse pleural thickening: natural history of radiographic and lung function abnormalities. Am J Respir Crit Care Med 153 (1996) 301-306
62. Miller A. Chronic pleuritic pain in four patients with asbestos induced pleural fibrosis. Br J Ind Med 7 (1990) 147-153
63. Mukherjee S., de Klerk N., Palmer L.J., et al. Chest pain in asbestos-exposed individuals with benign pleural and parenchymal disease. Am J Respir Crit Care Med 162 (2000) 1807-1811
64. Yates D.H., Browne K., Stidolph P.N., et al. Asbestos-related bilateral diffuse pleural thickening: natural history of radiographic and lung function abnormalities. Am J Respir Crit Care Med 153 (1996) 301-306
65. Kee S.T., Gamsu G., and Blanc P. Causes of pulmonary impairment in asbestos-exposed individuals with diffuse pleural thickening. Am J Respir Crit Care Med 154 (1996) 789-793
66. Wright P.H., Hanson A., Kreel L., et al. Respiratory function changes after asbestos pleurisy. Thorax 35 (1980) 31-36
67. Seibert A.F., Haynes J., Middleton R., et al. Tuberculous pleural effusion. Twenty years experience. Chest 99 (1991) 883-886
68. Mehta J.B., Dutt A., Havill L., et al. Epidemiology of extrapulmonary tuberculosis. A comparative analysis with pre-AIDS era. Chest 99 5 (1991) 1134-1138
69. de Pablo A., Villena V., Eschave Sustaeta J., et al. Are pleural fluid parameters related to the development of residual pleural thickening in tuberculosis. Chest 112 (1997) 1293-1297
70. Barbas C.S., Cukier A., de Varhalho C.R., et al. The relationship between pleural fluid findings and the development of pleural thickening in patients with pleural tuberculosis. Chest 100 (1991) 1264-1267
71. Wyser C., Walzl G., Smedema J., et al. Corticosteroids in the treatment of tuberculous pleurisy. A double-blind, placebo-controlled, randomized study. Chest 110 (1996) 333-338
72. Lee C.H., Wang W.J., Lan R.S., et al. Corticosteroids in the treatment of tuberculous pleurisy: a double-blind, placebo-controlled randomized study. Chest 94 (1988) 1256-1259
73. Galarza I., Cafiete C., Granados A., et al. Randomized trial of corticosteroids in the treatment of tuberculous pleurisy. Thorax 50 (1995) 1305-1307
74. Matchaba P.T., and Volmink J. Steroids for treating tuberculous pleurisy. Cochrane Database Syst Rev 2 (2000) CD001876
75. Brunk J.R., Drash E.C., and Swineford O. Rheumatoid pleuritis successfully treated with decortication. Report of a case and review of the literature. Am J Med Sci 251 (1966) 545-551
76. Joseph J., and Sahn S.A. Connective tissue diseases and the pleura. Chest 104 (1993) 262-270
77. Stanford R.E. Rheumatoid and other collagen lung disease. Semin Respir Med 4 (1982) 107-112
78. Jurik A.G., and Grudal H. Pleurisy in rheumatoid arthritis. Scand J Rheumatol 12 (1983) 75-80
79. Chapman P.T., O'Donnell J.L., and Moller P.W. Rheumatoid pleural effusion: response to intrapleural corticosteroids. J Rheumatol 19 (1992) 478-480
80. Russell M.L., Gladman D.D., and Mintz S. Rheumatoid pleural effusion: lack of response to intrapleural corticosteroids. J Rheumatol 13 (1986) 412-415
81. Brunk J.R., Drash E.C., and Swineford O. Rheumatoid pleuritis successfully treated with decortication. Report of a case and review of the literature. Am J Med Sci 251 (1966) 545-551
82. Yarbrough J.W., Sealy W.C., and Miller J.A. Thoracic surgical problems associated with rheumatoid arthritis. J Thorac Cardiovasc Surg 69 (1975) 347-354
83. Hopps H.C., and Wissler R.W. Uremic pneumonitis. Am J Pathol 31 (1955) 261-273
84. Maher J.F. Uremic pleuritis. Am J Kidney Dis 10 (1987) 19-22
85. Gilbert L., Ribot S., Frankel H., Jacobs M., et al. Fibrinous uremic pleuritis: a surgical entity. Chest 67 (1976) 53-56
86. Rodelas R., Rakowski T.A., Argy W.P., et al. Fibrosing uremic pleuritis during hemodialysis. JAMA 243 (1980) 2424-2425
87. Peng M.J., Vargas F.S., Cukier A., et al. Postoperative pleural changes after coronary revascularization. Chest 101 (1992) 327-330
88. Light R.W., Rogers J.T., Cheng D.S., et al. Large pleural effusions occurring after coronary bypass grafting. Ann Intern Med 130 (1999) 891-896
89. Hurlbut D., Myers M.L., Lefcoe M., et al. Pleuropulmonary morbidity: internal thoracic artery versus saphenous vein graft. Ann Thorac Surg 50 (1990) 959-964
90. Landymore R.W., and Howell F. Pulmonary complications following myocardial revascularization with the internal mammary artery graft. Eur J Cardiothorac Surg 4 (1990) 156-162
91. Lee Y.C.G., Vaz M.A.C., Ely K.A., et al. Symptomatic persistent post-coronary artery bypass graft pleural effusions requiring operative treatment: clinical and histologic features. Chest 119 (2001) 795-800
92. Lee Y.C.G., Vaz M.A.C., Ely K.A., et al. Symptomatic persistent post-coronary artery bypass graft pleural effusions requiring operative treatment: clinical and histologic features. Chest 119 (2001) 795-800
93. Wilson J.M., Boren C.H., Peterson S.R., et al. Traumatic hemothorax: is decortication necessary?. J Thorac Cardiovasc Surg 77 (1979) 489-495
94. Inci I., Ozcelik C., Ulku R., et al. Intrapleural fibrinolytic treatment of traumatic clotted hemothorax. Chest 114 (1998) 160-165
95. Jerjes-Sanchez C., Ramirez-Rivera A., Elizalde J.J., et al. Intrapleural fibrinolysis with streptokinase as an adjunctive treatment in hemothorax and empyema: a multicenter trial. Chest 109 (1996) 1514-1519
96. Pfitzenmeyer P., Foucher P., Dennewald G., et al. Pleuropulmonary changes induced by ergoline drugs. Eur Respir J 9 (1996) 1013-1019
97. Graham J.R., Suby H.I., LeCompte P.R., et al. Fibrotic disorders associated with methysergide therapy for headache. N Engl J Med 274 (1966) 350-368
98. McElvaney N.G., Wilcox P.G., Churg A., et al. Pleuropulmonary disease during bromocriptine treatment of Parkinson's disease. Arch Intern Med 148 (1988) 2231-2236
99. Bhatt M.H., Keenan S.P., Fleetham J.A., et al. Pleuropulmonary disease associated with dopamine agonist therapy. Ann Neurol 30 (1991) 613-616
100. De Vuyst P., Pfitzenmeyer P., and Camus P. Asbestos, ergot drugs, and the pleura. Eur Respir J 10 (1997) 2695-2698
101. Robert M., Derbaudrenghien J.P., Blampain J.P., et al. Fibrotic processes associated with long-term ergotamine therapy. N Engl J Med 311 (1984) 601-602
102. Malik S.W., Myers J.L., DeRemee R.A., et al. Lung toxicity associated with cyclophosphamide use. Two distinct patterns. Am J Respir Crit Care Med 154 (1996) 1851-1856
103. Standerskjold-Nordenstam C.G., Wandtke J.C., Hood W.J.J., et al. Amiodarone pulmonary toxicity. Chest radiography and CT in asymptomatic patients. Chest 88 (1985) 143-145
104. Gonzalez-Rothi R.J., Hannan S.E., Hood I., et al. Amiodarone pulmonary toxicity presenting as bilateral exudative effusions. Chest 92 (1987) 179-182
105. Stein B., Zaatari G.S., and Pine J.R. Amiodarone pulmonary toxicity. Clinical, cytological, and ultrastructural findings. Acta Cytol 31 (1987) 357-361
106. Buchanan D.R., Johnston I.D.A., Kerr I.H., et al. Cryptogenic bilateral fibrosing pleuritis. Br J Dis Chest 82 (1988) 186-193
107. Hayes J.P., Wiggins J., Ward K., et al. Familial cryptogenic fibrosing pleuritis with Fanconi's syndrome (renal tubular acidosis). A new syndrome. Chest 107 (1995) 576-578
108. Lee-Chiong Jr. T.L., and Hilbert J. Extensive idiopathic benign bilateral asynchronous pleural fibrosis. Chest 109 (1996) 564-565
109. Azoulaly E., Paugam B., Heymann M.F., et al. Familial extensive idiopathic bilateral pleural fibrosis. Eur Respir J 14 (1999) 971-973
110. Morton J.R., Boushy S.F., and Guinn G.A. Physiological evaluation of results of pulmonary decortication. Ann Thorac Surg 9 (1970) 321-326
111. Doelken P., and Sahn S.A. Trapped lung. Semin Respir Crit Care Med 22 (2001) 631-635
112. Light R.W., Stansbury D.W., and Brown S.E. Observations on pleural fluid pressures as fluid is withdrawn during thoracentesis. Am Rev Respir Dis 121 (1980) 799-804
113. Light R.W., Stansbury D.W., and Brown S.E. The relationship between pleural pressures and changes in pulmonary function after therapeutic thoracentesis. Am Rev Respir Dis 133 (1986) 658-661
114. Villena V., Lopez-Encuentra A., Pozo F., et al. Measurement of pleural pressures during therapeutic thoracentesis. Am J Respir Crit Care Med 162 (2000) 1534-1538
115. Lan R., Singh K.L., Chuang M., et al. Elastance of the pleural space: a predictor for the outcome of pleurodesis in patients with malignant effusions. Ann Intern Med 126 (1997) 768-774
116. Pien G.W., Gant M.J., Washam C.L., et al. Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion. Chest 119 (2001) 1641-1646